HOPA invites its Industry and Medical Education Partners to submit proposals for commercially supported symposia (CSS) to take place during HOPA's Annual Conference each year. CE and Non-CE Symposia are welcome.
The call for commercially sponsored symposia is currently closed but you can reserve a spot for Annual Conference 2025, which takes place April 9-12, 2025 in Portland Oregon.
Please complete this form: HOPA 2025 Annual Conference Early Bird Opportunities
HOPA welcomes applications for clinically relevant, scientifically sound, and unbiased programs that will provide oncology pharmacists with novel and innovative approaches to patient care. Supporters can develop and provide a 1-2 hour promotional or educational program in accordance with their own guidelines at the Annual Conference.
All CSS applications will be reviewed by the HOPA Program Committee to ensure they meet educational standards, fulfill clear educational objectives, meet the educational needs and are free of commercial bias.
Commercial supporters may not dictate the content of the symposia or the selection of faculty. HOPA will not provide continuing education credit for CSS. Evaluation and CPE Certificates/Certificates of Attendance are the responsibility of the CPE CSS provider.
These activities do not compete with CE programs, affording you an opportunity to present information on your branded or non-branded product as a workshop to attendees.
Please contact development@hoparx.org for more information.
The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously